{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:06:29Z","timestamp":1790744789352,"version":"4.1.0"},"reference-count":94,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1523,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1111\/j.1751-7133.2011.00240.x","type":"journal-article","created":{"date-parts":[[2011,7,21]],"date-time":"2011-07-21T07:23:55Z","timestamp":1311233035000},"page":"180-188","source":"Crossref","is-referenced-by-count":30,"title":["Renal Function in Advanced Heart Failure"],"prefix":"10.1111","volume":"17","author":[{"given":"Gregory","family":"Giamouzis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippos","family":"Triposkiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,7,21]]},"reference":[{"issue":"6-7","key":"10.1111\/j.1751-7133.2011.00240.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ejheart.2007.04.003","article-title":"Advanced chronic heart failure: a position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology","volume":"9","author":"Metra","year":"2007","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1111\/j.1751-7133.2011.00240.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1056\/NEJMoa051530","article-title":"Outcome of heart failure with preserved ejection fraction in a population-based study","volume":"355","author":"Bhatia","year":"2006","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1111\/j.1751-7133.2011.00240.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/hrt.2005.068296","article-title":"Non-cardiac comorbidities in chronic heart failure","volume":"93","author":"Lang","year":"2007","journal-title":"Heart"},{"issue":"1","key":"10.1111\/j.1751-7133.2011.00240.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cardfail.2010.08.010","article-title":"Hospitalization epidemic in patients with heart failure: risk factors, risk prediction, knowledge gaps, and future directions","volume":"17","author":"Giamouzis","year":"2011","journal-title":"J Card Fail"},{"issue":"10","key":"10.1111\/j.1751-7133.2011.00240.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.jacc.2005.11.084","article-title":"Renal impairment and outcomes in heart failure: systematic review and meta-analysis","volume":"47","author":"Smith","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"10.1111\/j.1751-7133.2011.00240.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1093\/eurheartj\/ehm480","article-title":"Renal dysfunction, as measured by the modification of diet in renal disease equations, and outcome in patients with advanced heart failure","volume":"28","author":"Gardner","year":"2007","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1111\/j.1751-7133.2011.00240.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.healun.2010.01.004","article-title":"Natural course and risk factors for impaired renal function during the first year after heart transplantation","volume":"29","author":"Jokinen","year":"2010","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"10.1111\/j.1751-7133.2011.00240.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.healun.2005.07.011","article-title":"Peri-operative renal function and outcome after orthotopic heart transplantation","volume":"25","author":"Odim","year":"2006","journal-title":"J Heart Lung Transplant"},{"issue":"11","key":"10.1111\/j.1751-7133.2011.00240.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.105.584102","article-title":"The Seattle Heart Failure Model: prediction of survival in heart failure","volume":"113","author":"Levy","year":"2006","journal-title":"Circulation"},{"issue":"2","key":"10.1111\/j.1751-7133.2011.00240.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ahj.2008.10.007","article-title":"Incremental value of renal function in risk prediction with the Seattle Heart Failure Model","volume":"157","author":"Giamouzis","year":"2009","journal-title":"Am Heart J"},{"issue":"4","key":"10.1111\/j.1751-7133.2011.00240.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jacc.2008.10.023","article-title":"Utility of the Seattle Heart Failure Model in patients with advanced heart failure","volume":"53","author":"Kalogeropoulos","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"10.1111\/j.1751-7133.2011.00240.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1161\/CIRCULATIONAHA.108.815944","article-title":"Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the Framingham heart study of the National Heart, Lung, and Blood Institute","volume":"119","author":"Lee","year":"2009","journal-title":"Circulation"},{"issue":"17","key":"10.1111\/j.1751-7133.2011.00240.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1001\/archinte.166.17.1884","article-title":"Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control","volume":"166","author":"Parikh","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1751-7133.2011.00240.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2165\/00003495-199000394-00004","article-title":"Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function","volume":"4","author":"Ljungman","year":"1990","journal-title":"Drugs"},{"issue":"9","key":"10.1111\/j.1751-7133.2011.00240.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ejheart.2007.05.010","article-title":"Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction","volume":"9","author":"Damman","year":"2007","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"10.1111\/j.1751-7133.2011.00240.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","article-title":"Importance of venous congestion for worsening of renal function in advanced decompensated heart failure","volume":"53","author":"Mullens","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"10.1111\/j.1751-7133.2011.00240.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1001\/jama.294.13.1625","article-title":"Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial","volume":"294","author":"Binanay","year":"2005","journal-title":"JAMA"},{"issue":"12","key":"10.1111\/j.1751-7133.2011.00240.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.amjcard.2010.07.050","article-title":"Characteristics of patients with improvement or worsening in renal function during treatment of acute decompensated heart failure","volume":"106","author":"Testani","year":"2010","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1111\/j.1751-7133.2011.00240.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ahj.2003.08.012","article-title":"Relationship between heart failure treatment and development of worsening renal function among hospitalized patients","volume":"147","author":"Butler","year":"2004","journal-title":"Am Heart J"},{"issue":"6","key":"10.1111\/j.1751-7133.2011.00240.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2459\/01.JCM.0000269715.95317.33","article-title":"Prevalence, predictors and prognostic value of acute impairment in renal function during intensive unloading therapy in a community population hospitalized for decompensated heart failure","volume":"8","author":"Cioffi","year":"2007","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"2","key":"10.1111\/j.1751-7133.2011.00240.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00003246-198402000-00005","article-title":"Reliability of clinical monitoring to assess blood volume in critically ill patients","volume":"12","author":"Shippy","year":"1984","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1111\/j.1751-7133.2011.00240.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/CIRCULATIONAHA.109.933275","article-title":"Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival","volume":"122","author":"Testani","year":"2010","journal-title":"Circulation"},{"key":"10.1111\/j.1751-7133.2011.00240.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1749-6632.2010.05724.x","article-title":"Innate inflammation in myocardial perfusion and its implication for heart failure","volume":"1207","author":"Picano","year":"2010","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"10.1111\/j.1751-7133.2011.00240.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jacc.2008.11.046","article-title":"The immune system and chronic heart failure: is the heart in control?","volume":"53","author":"Fildes","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1111\/j.1751-7133.2011.00240.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1475-097X.2009.00887.x","article-title":"Cardiac sympathetic activity is associated with inflammation and neurohumoral activation in patients with idiopathic dilated cardiomyopathy","volume":"29","author":"Turpeinen","year":"2009","journal-title":"Clin Physiol Funct Imaging"},{"issue":"2","key":"10.1111\/j.1751-7133.2011.00240.x-BIB26|cit26","first-page":"175","article-title":"Oxidative stress, inflammation and cardiovascular disease in chronic renal failure","volume":"21","author":"Cottone","year":"2008","journal-title":"J Nephrol"},{"issue":"5","key":"10.1111\/j.1751-7133.2011.00240.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1159\/000320749","article-title":"Rapid progression of diabetic nephropathy is linked to inflammation and episodes of acute renal failure","volume":"32","author":"Kelly","year":"2010","journal-title":"Am J Nephrol"},{"issue":"7","key":"10.1111\/j.1751-7133.2011.00240.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/eurjhf\/hfq104","article-title":"Loop diuretic therapy in left ventricular systolic dysfunction: has familiarity bred contempt for a critical but potentially nephrotoxic cardio renal therapy?","volume":"12","author":"MacFadyen","year":"2010","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10.1111\/j.1751-7133.2011.00240.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/clc.20771","article-title":"Loop diuretic therapy in heart failure: the need for solid evidence on a fluid issue","volume":"33","author":"Chiong","year":"2010","journal-title":"Clin Cardiol"},{"issue":"3-4","key":"10.1111\/j.1751-7133.2011.00240.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000047397","article-title":"Diuretic therapy and resistance in congestive heart failure","volume":"96","author":"Ellison","year":"2001","journal-title":"Cardiology"},{"issue":"19","key":"10.1111\/j.1751-7133.2011.00240.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jacc.2009.05.015","article-title":"The sympathetic nervous system in heart failure: physiology, pathophysiology, and clinical implications","volume":"54","author":"Triposkiadis","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1111\/j.1751-7133.2011.00240.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ki.1989.246","article-title":"Mechanism of impaired natriuretic response to furosemide during prolonged therapy","volume":"36","author":"Loon","year":"1989","journal-title":"Kidney Int"},{"issue":"12","key":"10.1111\/j.1751-7133.2011.00240.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1681\/ASN.V3121878","article-title":"A volume-independent component to postdiuretic sodium retention in humans","volume":"3","author":"Almeshari","year":"1993","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"10.1111\/j.1751-7133.2011.00240.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.cardfail.2010.07.246","article-title":"Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial","volume":"16","author":"Giamouzis","year":"2010","journal-title":"J Card Fail"},{"issue":"5","key":"10.1111\/j.1751-7133.2011.00240.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/01.CCM.0000124871.58281.D1","article-title":"Renal, but not systemic, hemodynamic effects of dopamine are influenced by the severity of congestive heart failure","volume":"32","author":"Ungar","year":"2004","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1111\/j.1751-7133.2011.00240.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/CIRCULATIONAHA.107.737106","article-title":"Renal vasodilatory action of dopamine in patients with heart failure: magnitude of effect and site of action","volume":"117","author":"Elkayam","year":"2008","journal-title":"Circulation"},{"issue":"1","key":"10.1111\/j.1751-7133.2011.00240.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/CIRCHEARTFAILURE.108.770834","article-title":"Blood urea nitrogen and serum creatinine: not married in heart failure","volume":"1","author":"Schrier","year":"2008","journal-title":"Circ Heart Fail"},{"issue":"2","key":"10.1111\/j.1751-7133.2011.00240.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/j.ajkd.2005.05.011","article-title":"Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index","volume":"46","author":"Verhave","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1111\/j.1751-7133.2011.00240.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/ki.2010.123","article-title":"Cardio-kidney-damage: a unifying concept","volume":"78","author":"El Nahas","year":"2010","journal-title":"Kidney Int"},{"issue":"17","key":"10.1111\/j.1751-7133.2011.00240.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the United States","volume":"298","author":"Coresh","year":"2007","journal-title":"JAMA"},{"key":"10.1111\/j.1751-7133.2011.00240.x-BIB41|cit41","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/293938","article-title":"Cardiorenal syndrome in acute heart failure syndromes","author":"Sarraf","year":"2011","journal-title":"Int J Nephrol"},{"issue":"4","key":"10.1111\/j.1751-7133.2011.00240.x-BIB42|cit42","first-page":"158","article-title":"[Cystatin C: a protein for heart failure.]","volume":"136","author":"Perez-Calvo","year":"2000","journal-title":"Med Clin (Barc)"},{"issue":"2","key":"10.1111\/j.1751-7133.2011.00240.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11897-011-0052-x","article-title":"Renal biomarkers of kidney injury in cardiorenal syndrome","volume":"8","author":"Comnick","year":"2011","journal-title":"Curr Heart Fail Rep"},{"issue":"1","key":"10.1111\/j.1751-7133.2011.00240.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4330\/wjc.v3.i1.1","article-title":"Cardiorenal syndromes","volume":"3","author":"McCullough","year":"2011","journal-title":"World J Cardiol"},{"issue":"15","key":"10.1111\/j.1751-7133.2011.00240.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa0912613","article-title":"Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure","volume":"363","author":"Massie","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1111\/j.1751-7133.2011.00240.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2005.07.067","article-title":"Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor?","volume":"47","author":"Schrier","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1111\/j.1751-7133.2011.00240.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJM199808063390607","article-title":"Diuretic therapy","volume":"339","author":"Brater","year":"1998","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1111\/j.1751-7133.2011.00240.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cardfail.2010.04.004","article-title":"HFSA 2010 comprehensive heart failure practice guideline","volume":"16","author":"Lindenfeld","year":"2010","journal-title":"J Card Fail"},{"issue":"12","key":"10.1111\/j.1751-7133.2011.00240.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.2215\/CJN.03150509","article-title":"Cardiorenal syndrome in acute decompensated heart failure","volume":"4","author":"Sarraf","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1111\/j.1751-7133.2011.00240.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-103-1-1","article-title":"Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis","volume":"103","author":"Francis","year":"1985","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1111\/j.1751-7133.2011.00240.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1161\/hc1102.105264","article-title":"BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy","volume":"105","author":"Gottlieb","year":"2002","journal-title":"Circulation"},{"issue":"8","key":"10.1111\/j.1751-7133.2011.00240.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.cardfail.2008.06.003","article-title":"Efficacy and safety of the vasopressin V1A\/V2-receptor antagonist conivaptan in acute decompensated heart failure: a dose-ranging pilot study","volume":"14","author":"Goldsmith","year":"2008","journal-title":"J Card Fail"},{"issue":"16","key":"10.1111\/j.1751-7133.2011.00240.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1001\/jama.291.16.1963","article-title":"Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial","volume":"291","author":"Gheorghiade","year":"2004","journal-title":"JAMA"},{"issue":"12","key":"10.1111\/j.1751-7133.2011.00240.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"issue":"5","key":"10.1111\/j.1751-7133.2011.00240.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.pcad.2009.11.005","article-title":"Congestion as a therapeutic target in acute heart failure syndromes","volume":"52","author":"Goldsmith","year":"2010","journal-title":"Prog Cardiovasc Dis"},{"issue":"11","key":"10.1111\/j.1751-7133.2011.00240.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/S0735-1097(03)00417-0","article-title":"Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality","volume":"41","author":"Kittleson","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1111\/j.1751-7133.2011.00240.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/archinte.160.5.685","article-title":"Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?","volume":"160","author":"Bakris","year":"2000","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1111\/j.1751-7133.2011.00240.x-BIB58|cit58","first-page":"193","article-title":"Renal insufficiency due to angiotensin-converting enzyme inhibitors","volume":"20","author":"Toto","year":"1994","journal-title":"Miner Electrolyte Metab"},{"issue":"9386","key":"10.1111\/j.1751-7133.2011.00240.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(03)14284-5","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial","volume":"362","author":"Granger","year":"2003","journal-title":"Lancet"},{"issue":"22","key":"10.1111\/j.1751-7133.2011.00240.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1111\/j.1751-7133.2011.00240.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0735-1097(01)01516-9","article-title":"Metoprolol controlled release\/extended release in patients with severe heart failure: analysis of the experience in the MERIT-HF study","volume":"38","author":"Goldstein","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1111\/j.1751-7133.2011.00240.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/01.CIR.0000116764.53225.A9","article-title":"Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study","volume":"109","author":"McAlister","year":"2004","journal-title":"Circulation"},{"issue":"8","key":"10.1111\/j.1751-7133.2011.00240.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jacc.2004.06.072","article-title":"The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease","volume":"44","author":"Ezekowitz","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1111\/j.1751-7133.2011.00240.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.cardfail.2008.11.003","article-title":"The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR\/XL Randomized Intervention Trial in Chronic HF (MERIT-HF)","volume":"15","author":"Ghali","year":"2009","journal-title":"J Card Fail"},{"issue":"2","key":"10.1111\/j.1751-7133.2011.00240.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5414\/CPP45071","article-title":"Acute hemodynamic effects of moderate doses of nebivolol versus metoprolol in patients with systolic heart failure","volume":"45","author":"Triposkiadis","year":"2007","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"1","key":"10.1111\/j.1751-7133.2011.00240.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1111\/j.1751-7133.2011.00240.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1111\/j.1751-7133.2011.00240.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa040135","article-title":"Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study","volume":"351","author":"Juurlink","year":"2004","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1111\/j.1751-7133.2011.00240.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1161\/CIRCULATIONAHA.108.778811","article-title":"Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS)","volume":"118","author":"Pitt","year":"2008","journal-title":"Circulation"},{"key":"10.1111\/j.1751-7133.2011.00240.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"c1768","DOI":"10.1136\/bmj.c1768","article-title":"Spironolactone use and renal toxicity: population based longitudinal analysis","volume":"340","author":"Wei","year":"2010","journal-title":"BMJ"},{"issue":"20","key":"10.1111\/j.1751-7133.2011.00240.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa042934","article-title":"Combination of isosorbide dinitrate and hydralazine in blacks with heart failure","volume":"351","author":"Taylor","year":"2004","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1111\/j.1751-7133.2011.00240.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1161\/CIRCULATIONAHA.106.644013","article-title":"Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate\/hydralazine: consistency across subgroups in the African-American Heart Failure Trial","volume":"115","author":"Taylor","year":"2007","journal-title":"Circulation"},{"issue":"2","key":"10.1111\/j.1751-7133.2011.00240.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/eurheartj\/ehi687","article-title":"Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial","volume":"27","author":"Ahmed","year":"2006","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1111\/j.1751-7133.2011.00240.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1097\/01.ASN.0000135121.81744.75","article-title":"Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial","volume":"15","author":"Shlipak","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1111\/j.1751-7133.2011.00240.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1161\/CIRCHEARTFAILURE.108.807032","article-title":"Digoxin therapy does not improve outcomes in patients with advanced heart failure on contemporary medical therapy","volume":"2","author":"Georgiopoulou","year":"2009","journal-title":"Circ Heart Fail"},{"issue":"Suppl","key":"10.1111\/j.1751-7133.2011.00240.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1097\/01.CCM.0000296273.72952.39","article-title":"Inotropes in the management of acute heart failure","volume":"1","author":"Petersen","year":"2008","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1111\/j.1751-7133.2011.00240.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1517\/13543780902922660","article-title":"Current drugs and medical treatment algorithms in the management of acute decompensated heart failure","volume":"18","author":"Triposkiadis","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"issue":"6A","key":"10.1111\/j.1751-7133.2011.00240.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"47G","DOI":"10.1016\/j.amjcard.2005.07.021","article-title":"Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes","volume":"96","author":"Bayram","year":"2005","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1111\/j.1751-7133.2011.00240.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/FJC.0b013e3181684026","article-title":"The effects of dobutamine on renal sympathetic activity in human heart failure","volume":"51","author":"Al-Hesayen","year":"2008","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"10.1111\/j.1751-7133.2011.00240.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"136","DOI":"10.5414\/CPP46136","article-title":"Hemodynamic effects of dobutamine in patients with an exacerbation of chronic systolic heart failure treated with low doses of carvedilol","volume":"46","author":"Triposkiadis","year":"2008","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"10","key":"10.1111\/j.1751-7133.2011.00240.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/CIRCULATIONAHA.107.728840","article-title":"Inotropes and vasopressors: review of physiology and clinical use in cardiovascular disease","volume":"118","author":"Overgaard","year":"2008","journal-title":"Circulation"},{"key":"10.1111\/j.1751-7133.2011.00240.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0002-8703(99)70107-9","article-title":"Intermittent milrinone effect on long-term hemodynamic profile in patients with severe congestive heart failure","volume":"1","author":"Hatzizacharias","year":"1999","journal-title":"Am Heart J"},{"issue":"1","key":"10.1111\/j.1751-7133.2011.00240.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/CIRCHEARTFAILURE.107.746933","article-title":"Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF)","volume":"1","author":"Klein","year":"2008","journal-title":"Circ Heart Fail"},{"issue":"5","key":"10.1111\/j.1751-7133.2011.00240.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0009-9236(97)90139-9","article-title":"Myocardial efficiency during calcium sensitization with levosimendan: a noninvasive study with positron emission tomography and echocardiography in healthy volunteers","volume":"61","author":"Ukkonen","year":"1997","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1111\/j.1751-7133.2011.00240.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1067\/mcp.2000.110972","article-title":"Myocardial efficiency during levosimendan infusion in congestive heart failure","volume":"68","author":"Ukkonen","year":"2000","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"10.1111\/j.1751-7133.2011.00240.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ejheart.2008.08.005","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)","volume":"10","author":"Dickstein","year":"2008","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10.1111\/j.1751-7133.2011.00240.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cardfail.2007.03.005","article-title":"Levosimendan improves renal function in patients with advanced chronic heart failure awaiting cardiac transplantation","volume":"13","author":"Zemljic","year":"2007","journal-title":"J Card Fail"},{"issue":"6","key":"10.1111\/j.1751-7133.2011.00240.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10557-007-6066-7","article-title":"Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine","volume":"21","author":"Yilmaz","year":"2007","journal-title":"Cardiovasc Drugs Ther"},{"issue":"4","key":"10.1111\/j.1751-7133.2011.00240.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10741-008-9128-4","article-title":"Levosimendan: from basic science to clinical practice","volume":"14","author":"Parissis","year":"2009","journal-title":"Heart Fail Rev"},{"issue":"6","key":"10.1111\/j.1751-7133.2011.00240.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10557-007-6070-y","article-title":"Levosimendan improves renal function in acute decompensated heart failure: cause and clinical application. Editorial to: \u201cLevosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine by Yilmaz et\u00a0al.\u201d","volume":"21","author":"Damman","year":"2007","journal-title":"Cardiovasc Drugs Ther"},{"issue":"1","key":"10.1111\/j.1751-7133.2011.00240.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijcard.2008.01.034","article-title":"Natriuretic peptide-guided levosimendan therapy for heart failure: a promising new approach","volume":"128","author":"Giamouzis","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1111\/j.1751-7133.2011.00240.x-BIB92|cit92","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/190230","article-title":"The role of ultrafiltration in patients with decompensated heart failure","author":"Kamath","year":"2011","journal-title":"Int J Nephrol"},{"issue":"3","key":"10.1111\/j.1751-7133.2011.00240.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ahj.2010.09.014","article-title":"Ultrafiltration in heart failure","volume":"161","author":"Fiaccadori","year":"2011","journal-title":"Am Heart J"},{"issue":"6","key":"10.1111\/j.1751-7133.2011.00240.x-BIB94|cit94","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jacc.2006.07.073","article-title":"Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure","volume":"49","author":"Costanzo","year":"2007","journal-title":"J Am Coll Cardiol"}],"container-title":["Congestive Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1751-7133.2011.00240.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,28]],"date-time":"2021-11-28T12:47:21Z","timestamp":1638103641000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1751-7133.2011.00240.x"}},"subtitle":["renal function in advanced heart failure"],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":94,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1751-7133.2011.00240.x","relation":{},"ISSN":["1527-5299"],"issn-type":[{"value":"1527-5299","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}